BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34931855)

  • 21. The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.
    Takamatsu K; Matsumoto K; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Shinojima T; Kikuchi E; Asanuma H; Oya M
    Urol Oncol; 2019 Sep; 37(9):575.e19-575.e25. PubMed ID: 30967332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiological Wheeler staging system: a retrospective cohort analysis to improve the local staging of prostate cancer with multiparametric MRI.
    Russo F; Manfredi M; Panebianco V; Armando E; De Luca S; Mazzetti S; Giannini V; Mele F; Bollito E; Appendino E; Regge D; Porpiglia F
    Minerva Urol Nefrol; 2019 Jun; 71(3):264-272. PubMed ID: 30654601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease.
    Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE
    Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.
    Chuang AY; Nielsen ME; Hernandez DJ; Walsh PC; Epstein JI
    J Urol; 2007 Oct; 178(4 Pt 1):1306-10. PubMed ID: 17698141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
    Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
    Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
    Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
    DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
    Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staging of prostatic carcinoma at 1.5-T MRI: correlation of a simplified MRI exam with whole-mount radical prostatectomy specimens.
    Van Holsbeeck A; Degroote A; De Wever L; Vanhoutte E; De Keyzer F; Van Poppel H; Oyen R
    Br J Radiol; 2016 Jul; 89(1063):20160101. PubMed ID: 27181821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.
    Sugano D; Sidana A; Jain AL; Calio B; Gaur S; Maruf M; Merino M; Choyke P; Turkbey B; Wood BJ; Pinto PA
    Int Urol Nephrol; 2019 Aug; 51(8):1349-1355. PubMed ID: 31098818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non-organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy.
    Eineluoto JT; Sandeman K; Pohjonen J; Sopyllo K; Nordling S; Stürenberg C; Malén A; Kilpeläinen TP; Santti H; Petas A; Matikainen M; Pellinen T; Järvinen P; Kenttämies A; Rannikko A; Mirtti T
    Eur Urol Focus; 2021 Nov; 7(6):1316-1323. PubMed ID: 32620540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Anterior and Lateral Extraprostatic Extensions with Base-Positive Resection Margins in Prostate Cancer.
    Kang YJ; Abalajon MJ; Jang WS; Kwon JK; Yoon CY; Lee JY; Cho KS; Ham WS; Choi YD
    PLoS One; 2016; 11(7):e0158922. PubMed ID: 27391650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings.
    Wibmer AG; Chaim J; Lakhman Y; Lefkowitz RA; Nincevic J; Nikolovski I; Sala E; Gonen M; Carlsson SV; Fine SW; Zelefsky MJ; Scardino P; Hricak H; Vargas HA
    J Urol; 2021 Apr; 205(4):1055-1062. PubMed ID: 33207133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
    Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraprostatic Tumor Extension: Comparison of Preoperative Multiparametric MRI Criteria and Histopathologic Correlation after Radical Prostatectomy.
    Park KJ; Kim MH; Kim JK
    Radiology; 2020 Jul; 296(1):87-95. PubMed ID: 32368959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate Cancer Risk Stratification by Simple Scoring of the Current pT3 Lesions: A Proposal for a New Pathologic T-Staging System.
    Miyamoto H; Teramoto Y; Numbere N; Wang Y; Joseph JV
    Mod Pathol; 2024 Mar; 37(3):100429. PubMed ID: 38266919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy.
    Ruprecht O; Weisser P; Bodelle B; Ackermann H; Vogl TJ
    Eur J Radiol; 2012 Mar; 81(3):456-60. PubMed ID: 21354732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Performance of Prospectively Assigned Likert Scale Scores to Determine Extraprostatic Extension and Seminal Vesicle Invasion With Multiparametric MRI of the Prostate.
    Freifeld Y; Diaz de Leon A; Xi Y; Pedrosa I; Roehrborn CG; Lotan Y; Francis F; Costa DN
    AJR Am J Roentgenol; 2019 Mar; 212(3):576-581. PubMed ID: 30589381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.